InnovAge Holding (InnovAge Holding) EBIT : $-29.5 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is InnovAge Holding EBIT?

InnovAge Holding's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-5.4 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-29.5 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. InnovAge Holding's annualized ROC % for the quarter that ended in Mar. 2024 was -5.13%. InnovAge Holding's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -9.74%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. InnovAge Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -4.69%.

InnovAge Holding EBIT Historical Data

The historical data trend for InnovAge Holding's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovAge Holding EBIT Chart

InnovAge Holding Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT

34.98

50.25

-18.18

-4.71

-49.27

InnovAge Holding Quarterly Data
	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial														-8.27	-11.20	-10.08	-2.79	-5.39

Competitive Comparison of InnovAge Holding's EBIT

For the Medical Care Facilities subindustry, InnovAge Holding's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InnovAge Holding's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where InnovAge Holding's EV-to-EBIT falls into.

InnovAge Holding EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.5 Mil.

InnovAge Holding (NAS:INNV) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

InnovAge Holding's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-23.172 * ( 1 - 3.5% )	/	( (436.582	+	435.959)	/ 2 )
=	-22.36098	/	436.2705
=	-5.13 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	534.262	-	63.848	-	( 98.771	-	max(0, 123.132	-	156.964	+	98.771	))
=	436.582

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	527.355	-	60.303	-	( 99.33	-	max(0, 121.973	-	153.066	+	99.33	))
=	435.959

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

InnovAge Holding's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-21.544	/	( ( (222.1 + max(-53.164, 0))	+	(220.308 + max(-59.178, 0)) )	/	2 )
=	-21.544	/	( ( 222.1	+	220.308 )	/	2 )
=	-21.544	/	221.204
=	-9.74 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(43.456	+	0	+	14.475)	-	(63.848	+	0	+	47.247)
=	-53.164

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(36.457	+	0	+	13.949)	-	(60.303	+	0	+	49.281)
=	-59.178

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

InnovAge Holding's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-29.452	/	628.624
	=	-4.69 %

InnovAge Holding EBIT Related Terms

Thank you for viewing the detailed overview of InnovAge Holding's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

InnovAge Holding (InnovAge Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovAge Holding Corp (NAS:INNV) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

8950 East Lowry Boulevard, Denver, CO, USA, 80230

Website

https://www.innovage.com

InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.

Executives

Teresa Sparks	director	40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Nicole Damato	officer: CHIEF LEGAL OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Benjamin C Adams	officer: CHIEF FINANCIAL OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patricia Fontneau	director	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Christine Bent	officer: CHIEF OPERATIONS OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Thomas Scully	director	320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022
Richard Feifer	officer: CHIEF MEDICAL OFFICER	C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348
James G Carlson	director	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patrick T Blair	officer: PRESIDENT	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Caroline Dechert	director	580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104
Pavithra Mahesh	director	601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022
Maureen Hewitt	director, officer: CEO, President and Director	8950 E. LOWRY BLVD., DENVER CO 80230
Maria Lozzano	officer: CORPORATE COO	8950 E. LOWRY BLVD., DENVER CO 80230
Robin Doerr	officer: CHIEF SALES AND MKTG. OFFICER	8950 E. LOWRY BLVD., DENVER CO 80230
Melissa Welch	officer: CHIEF MEDICAL OFFICER	8950 E. LOWRY BLVD., DENVER CO 80230